Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Endothelin antagonism: a new era for resistant hypertension?
Gavin Chapman
,
Neeraj Dhaun
*
*
Corresponding author for this work
Deanery of Clinical Sciences
Centre for Cardiovascular Science
Edinburgh Imaging
Research output
:
Contribution to journal
›
Editorial
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endothelin antagonism: a new era for resistant hypertension?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Endothelin
100%
Resistant Hypertension
100%
Prevalence
50%
Chronic Kidney Failure
50%
Antihypertensive Agent
50%
Coronary Artery Disease
50%
Diseases
50%
Diuretics
50%
Maximum Tolerated Dose
50%